Alps Advisors Inc Biotechnology

Alps Advisors Inc

$15.7 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
EXEL Exelixis, Inc.	$11.9B	$432,000 0.0% of portfolio	13,000	Q3 2024 New
SVRA Savara Inc	$325M	$426,000 0.0% of portfolio	138,771	Q4 2024 Added 7.99%
TGTX Tg Therapeutics, Inc.	$5.79B	$425,000 0.0% of portfolio	14,150	Q4 2024 Reduced 1.39%
ATXS Astria Therapeutics, Inc.	$86.5M	$402,000 0.0% of portfolio	45,630	Q4 2024 New
CELC Celcuity Inc.	$158M	$393,000 0.0% of portfolio	30,028	Q4 2024 Reduced 0.22%
TBPH Theravance Biopharma, Inc.	$616M	$374,000 0.0% of portfolio	39,759	Q4 2024 Added 6.21%
ARCT Arcturus Therapeutics Holdings Inc.	$308M	$371,000 0.0% of portfolio	21,901	Q4 2024 Added 0.29%
URGN Uro Gen Pharma Ltd.	$255M	$363,000 0.0% of portfolio	34,121	Q4 2024 Reduced 0.08%
CPRX Catalyst Pharmaceuticals, Inc.	$2.54B	$357,000 0.0% of portfolio	17,109	Q4 2024 Reduced 2.28%
UTHR United Therapeutics Corp	$14B	$356,000 0.0% of portfolio	1,011	Q4 2024 Reduced 0.49%
BMRN Biomarin Pharmaceutical Inc	$13.1B	$335,000 0.0% of portfolio	5,100	Q3 2024 New
AURA Aura Biosciences, Inc.	$186M	$332,000 0.0% of portfolio	40,392	Q4 2024 Added 14.71%
ADMA Adma Biologics, Inc.	$3.98B	$330,000 0.0% of portfolio	19,250	Q4 2024 Reduced 2.04%
HRMY Harmony Biosciences Holdings, Inc.	$1.96B	$318,000 0.0% of portfolio	9,244	Q3 2024 Reduced 17.67%
VRTX Vertex Pharmaceuticals Inc	$124B	$317,000 0.0% of portfolio	788	Q4 2024 Reduced 2.11%
YMAB Y M Abs Therapeutics, Inc.	$210M	$283,000 0.0% of portfolio	36,215	Q4 2024 Added 5.8%
HALO Halozyme Therapeutics, Inc.	$8.89B	$271,000 0.0% of portfolio	5,687	Q3 2024 Reduced 32.2%
OLMA Olema Pharmaceuticals, Inc.	$171M	$270,000 0.0% of portfolio	46,335	Q4 2024 Added 1.41%
ALDX Aldeyra Therapeutics, Inc.	$389M	$240,000 0.0% of portfolio	48,155	Q4 2024 Added 5.75%
ITOS I Teos Therapeutics, Inc.	$225M	$226,000 0.0% of portfolio	29,540	Q4 2024 Added 11.58%
VNDA Vanda Pharmaceuticals Inc.	$265M	$225,000 0.0% of portfolio	47,149	Q4 2024 Added 7.07%
RZLT Rezolute, Inc.	$114M	$223,000 0.0% of portfolio	46,850	Q4 2024 New
REGN Regeneron Pharmaceuticals, Inc.	$68B	$220,000 0.0% of portfolio	310	Q3 2024 New
AMLX Amylyx Pharmaceuticals, Inc.	$214M	$208,000 0.0% of portfolio	55,430	Q4 2024 New
FDMT 4 D Molecular Therapeutics, Inc.	$118M	$208,000 0.0% of portfolio	37,379	Q4 2024 Reduced 4.99%
ELDN Eledon Pharmaceuticals, Inc.	$46.1M	$197,000 0.0% of portfolio	48,310	Q4 2024 New
LRMR Larimar Therapeutics, Inc.	$102M	$197,000 0.0% of portfolio	51,590	Q4 2024 New
ZNTL Zentalis Pharmaceuticals, Inc.	$103M	$174,000 0.0% of portfolio	57,587	Q4 2024 Added 2.44%
PROK Prokidney Corp Ord Shs Cl A(Cy	$56M	$174,000 0.0% of portfolio	103,477	Q4 2024 Added 6.24%
MGNX Macrogenics Inc	$77.4M	$164,000 0.0% of portfolio	50,750	Q4 2024 New
ALEC Alector, Inc.	$107M	$149,000 0.0% of portfolio	79,115	Q4 2024 Added 2.44%
STRO Sutro Biopharma, Inc.	$38.6M	$122,000 0.0% of portfolio	66,646	Q4 2024 Added 2.44%
ENTA Enanta Pharmaceuticals Inc	$118M	$98,000 0.0% of portfolio	17,137	Q4 2024 Added 6.85%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.